Simplex Trading’s PMV Pharmaceuticals PMVP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-300
Closed -$1K 9581
2023
Q3
$1K Buy
+300
New +$2.06K ﹤0.01% 8394
2023
Q1
Sell
-4,700
Closed -$40K 9877
2022
Q4
$40K Buy
4,700
+4,600
+4,600% +$49K ﹤0.01% 6158
2022
Q3
$1K Sell
100
-1,300
-93% -$18.8K ﹤0.01% 9607
2022
Q2
$19K Sell
1,400
-3,100
-69% -$45.1K ﹤0.01% 7677
2022
Q1
$93K Buy
+4,500
New +$79.4K ﹤0.01% 6259

Other funds holding PMVP

Simplex Trading's PMVP Position: Q1 2026 in Review

Simplex Trading reduced its PMV Pharmaceuticals (PMVP) stake by 71% in Q1 2026, selling an estimated $25K and leaving 8,181 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7346.

Simplex Trading first reported a position in PMVP in Q4 2021 and has held it in 14 quarters since. The position peaked at $694K in Q2 2022. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Simplex Trading held 8,181 shares of PMV Pharmaceuticals worth $10.1K as of Q1 2026.
  • Simplex Trading sold 19,681 PMV Pharmaceuticals shares in Q1 2026, an estimated $25K.
  • PMV Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7346 holding.
  • Simplex Trading first reported a position in PMV Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
  • Simplex Trading's PMV Pharmaceuticals position peaked at $694K in Q2 2022.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.